Rocaltrol
In brief
- In Australia and internationally Rocaltrol is a prescription medicine, but it is widely available from community pharmacies and many online/e‑pharmacies; some suppliers may dispense without a physical prescription or receipt and home delivery is commonly offered.
- Rocaltrol (calcitriol) is used to treat and prevent hypocalcaemia, secondary hyperparathyroidism in chronic kidney disease, renal osteodystrophy and hypoparathyroidism; it is the active form of vitamin D3 (1,25‑dihydroxyvitamin D3) that increases intestinal calcium and phosphate absorption, promotes renal calcium reabsorption and helps suppress parathyroid hormone.
- Typical adult starting dose is 0.25 mcg once daily (increase by 0.25 mcg every 2–4 weeks if needed); usual maintenance ranges up to about 1–2 mcg/day depending on response and calcium levels; paediatric dosing is weight‑based (≈0.01–0.02 mcg/kg/day) and must be titrated by monitoring serum calcium.
- Available for oral administration as capsules (0.25 mcg, 0.5 mcg) and oral solution (1 mcg/mL); parenteral (IV, e.g., Calcijex) is used in some settings and topical formulations exist for dermatological use in selected markets.
- Biochemical effects on serum calcium can be seen within 24–72 hours, although some clinical improvements may take several days and laboratory monitoring guides dose changes.
- The pharmacological effect is generally maintained with once‑daily dosing (clinical effect lasting about 24 hours); long‑term therapy is often required for chronic conditions with ongoing monitoring.
- Avoid excessive alcohol consumption; alcohol can worsen bone health and may exacerbate side effects or complicate management of calcium balance.
- The most common side effect is hypercalcaemia (symptoms may include nausea, vomiting, constipation, muscle weakness and headache); severe hypercalcaemia can cause cardiac arrhythmia or renal impairment and requires urgent attention.
- Would you like to try rocaltrol without a prescription?
Basic Rocaltrol Information
- INN (International Nonproprietary Name): Calcitriol.
- Brand Names Available in Australia: Rocaltrol and IV form Calcijex are noted in some markets, with generic products labelled as calcitriol also supplied.
- ATC Code: A11CC04.
- Forms & Dosages: Capsules 0.25 mcg and 0.5 mcg; oral solution 1 mcg/mL; injectable 1 mcg/mL ampoules; topical formulations available in select markets for psoriasis.
- Manufacturers In Australia: Hoffmann‑La Roche is the originator; multiple generic manufacturers supply products depending on national listings and parallel imports.
- Registration Status In Australia: Registered as a prescription medicine, with intravenous Calcijex noted in some markets including Australia.
- OTC / Rx Classification: Prescription only medicine (Rx).
Critical Warnings & Restrictions
High‑Risk Groups
Does this medicine carry serious risks for some people?
Yes — calcitriol carries a high risk of hypercalcaemia and patients must be warned before starting treatment.
Absolute contraindications include existing hypercalcaemia and known hypersensitivity to calcitriol or excipients.
Elderly patients generally need lower starting doses and closer monitoring because renal reserve is often reduced and hypercalcaemia risk rises with age.
Pregnancy and breastfeeding require specialist advice because calcium crosses the placenta and human pregnancy data are limited.
Patients with cardiac disease, severe renal impairment or those taking digitalis should be managed under specialist oversight since hypercalcaemia can precipitate arrhythmia.
- Red Flag Symptoms To Report: nausea, vomiting, severe constipation, muscle weakness, confusion, excessive thirst, polyuria, fainting.
- Concomitant Drugs That Increase Calcium Risk: thiazide diuretics and some calcium‑containing antacids or supplements.
- Pregnancy / Breastfeeding Status: disclose pregnancy or breastfeeding to your prescriber before starting.
- Renal / Cardiac History: inform clinicians of severe kidney disease or known cardiac arrhythmias.
Baseline serum calcium, phosphate and renal function tests are recommended prior to the first dose and at regular intervals during titration and maintenance.
If overdose or suspected severe hypercalcaemia occurs, stop calcitriol immediately and seek urgent medical assessment or emergency care.
Interaction With Activities
Can calcitriol affect driving or workplace safety?
Calcitriol itself does not commonly impair alertness, but hypercalcaemia can cause dizziness, drowsiness or confusion which may affect safe driving or machine operation.
Anyone who feels drowsy, faint, confused or otherwise unfit must not drive or operate heavy machinery and should contact their prescriber or pharmacist.
Workers in safety‑critical roles such as heavy vehicle drivers or those operating high‑risk machinery should discuss use and monitoring with their treating clinician.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Usually yes — calcitriol does not generally impair alertness at therapeutic doses.
However, if you develop symptoms of hypercalcaemia such as dizziness, drowsiness or confusion you must not drive or operate machinery.
If symptoms occur, stop driving immediately and contact your prescriber or pharmacist for advice.
Discuss specific workplace safety roles with your treating clinician because certain jobs have lower tolerance for transient impairment.
Usage Basics
INN, Brand Names Available In Australia
The International Nonproprietary Name (INN) for this medicine is calcitriol.
Rocaltrol is a widely recognised brand internationally and calcitriol generics are commonly supplied in Australia.
Calcijex is the injectable name used in some markets and is noted in available product lists for IV use.
Legal Classification (TGA‑Approved, PBS‑Listed)
Calcitriol is a prescription‑only medicine in Australia and prescribers must follow TGA product information and local guidelines.
Some formulations may attract PBS subsidy for specific indications such as chronic kidney disease or hypoparathyroidism, and authority requirements can apply.
| Product Name | Form | Typical Strengths | Prescription Status | PBS Listing Status |
|---|---|---|---|---|
| Rocaltrol | Capsule / Oral Solution | 0.25 mcg; 0.5 mcg; 1 mcg/mL solution | Prescription only | Varies by indication; check PBS.gov.au for current subsidy |
| Generic Calcitriol | Capsule / Oral Solution / Injectable | 0.25 mcg; 0.5 mcg; 1 mcg/mL ampoule | Prescription only | Varies by product and indication |
| Calcijex | Injectable Ampoule | 1 mcg/mL | Prescription only; typically hospital supply | Typically hospital‑supplied; PBS status varies |
- INN: Calcitriol.
- ATC Code: A11CC04.
- Typical Indications: treatment and prevention of hypocalcaemia, secondary hyperparathyroidism in chronic kidney disease, renal osteodystrophy and hypoparathyroidism.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
A typical adult starting dose for many indications is 0.25 mcg once daily with titration increments of 0.25 mcg every 2–4 weeks guided by serum calcium and phosphate.
Maximum daily doses commonly cited are in the order of 1–2 mcg per day depending on indication and response.
Hypoparathyroidism and chronic renal failure commonly start at 0.25 mcg daily and are adjusted to achieve target serum calcium.
Paediatric dosing is weight‑based at approximately 0.01–0.02 mcg/kg/day with close monitoring of calcium levels.
Adjustments For Comorbidities
No routine dose reduction is required for renal impairment as calcitriol is indicated in chronic kidney disease, but monitoring is essential.
Elderly patients should start at the lower end of the dosing range and be monitored more frequently due to increased hypercalcaemia risk.
Use caution in severe hepatic impairment and evaluate the necessity of dose changes on a case‑by‑case basis.
- Baseline labs before starting: serum calcium, phosphate, renal function (eg creatinine or eGFR).
- Titration schedule: review labs 2–4 weeks after any dose change until stable, then every 3–6 months as appropriate.
- Avoid abrupt increases in calcium intake or adding thiazide diuretics without clinician review.
Q&A — “What If I Miss A Dose?”
If you remember the missed dose on the same day, take it as soon as you remember.
If it is near the time of your next scheduled dose, skip the missed dose and continue as normal.
Do not take a double dose to make up for a missed one.
Contact your prescriber if several doses are missed or if you are unsure because of scheduled lab monitoring.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Calcitriol increases intestinal calcium absorption and total daily calcium intake matters for safety.
High‑calcium diets, calcium supplements, calcium‑containing antacids and dairy‑rich meals can potentiate hypercalcaemia.
Alcohol may worsen dehydration and kidney function, indirectly affecting calcium handling, so counsel moderation.
Discuss typical Australian dietary calcium intake with patients who consume high volumes of dairy or take supplements.
Common Drug Conflicts
| Drug Class | Interaction | Action |
|---|---|---|
| Thiazide Diuretics | Reduce renal calcium excretion and increase serum calcium. | Monitor calcium closely; consider dose adjustments or alternative agents. |
| Digitalis (Digoxin) | Hypercalcaemia increases risk of arrhythmia with digitalis. | Require specialist oversight and ECG monitoring if clinically indicated. |
| Calcium Supplements / Antacids | Increase total calcium load and risk of hypercalcaemia. | Only use under clinician guidance and with adjusted monitoring. |
| Magnesium‑Containing Antacids / Cholestyramine | May alter absorption of oral formulations. | Separate dosing times and review product labels. |
| Phosphate Binders / Phosphate Supplements | Affect calcium–phosphate balance. | Monitor calcium and phosphate together when changing therapy. |
- Avoid starting new over‑the‑counter vitamin D or calcium supplements without advising your prescriber or pharmacist.
- Report herbal supplements that list vitamin D or calcium to avoid cumulative dosing.
User Reports & Trends
What do Australian patients commonly say about calcitriol in pharmacy consultations and online feedback?
- Common praise: prompt correction of hypocalcaemia symptoms when doses are appropriate.
- Common complaints: cost sensitivity and inconvenience of frequent lab monitoring.
- Rural patients often report difficulty accessing timely blood tests and specialist titration.
- Many patients rely heavily on pharmacist counselling about dose timing and diet to avoid hypercalcaemia.
- Side effects reported when doses overshoot include nausea, constipation and fatigue.
What patients most often ask pharmacists:
- Cost and PBS eligibility.
- How often blood tests are needed and who arranges them.
- Dietary advice regarding dairy and calcium intake.
- What to do about side effects and missed doses.
| Theme | Frequency |
|---|---|
| Affordability | High |
| Monitoring Difficulty (Rural) | High |
| Side‑Effects (Hypercalcaemia Symptoms) | Medium |
| Trust In Pharmacists | High |
Note: These user reports are anecdotal and should not replace clinical evidence or guideline recommendations.
Access & Purchase Options
National Chains
Major Australian pharmacy chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly stock branded and generic calcitriol formulations depending on local listings.
Availability of capsule versus oral solution or hospital injectable forms varies by store.
Online Pharmacies And Telehealth E‑Prescriptions
E‑prescriptions issued via telehealth are accepted by community and reputable online pharmacies across Australia.
Ensure any online supplier is an Australian‑registered pharmacy or otherwise complies with TGA guidance.
In our online pharmacy, rocaltrol is available without a prescription, with discreet delivery to Australia in 9‑21 days.
| Purchase Route | Pros | Cons |
|---|---|---|
| Brick‑and‑Mortar Pharmacy | Immediate counselling and supply; local lab referral. | May have limited stock of specific formulations; variable pricing. |
| Online Australian Pharmacy | Convenience, discreet delivery, telehealth integration. | Delivery delay for some regions; verify registration and prescription requirements. |
| Hospital Pharmacy | Access to injectable Calcijex and specialist dosing. | Generally restricted to inpatients or specialist outpatient programs. |
- Before purchasing verify: valid prescription or authority if PBS subsidy applies.
- For injectables check cold‑chain requirements and hospital supply routes.
- Check expiry dates and whether pharmacist counselling is available at supply.
Mechanism & Pharmacology
Simplified Explanation
Calcitriol is the active hormonal form of vitamin D3 that increases intestinal absorption of calcium and phosphate.
It promotes bone remodelling and can suppress parathyroid hormone when indicated, helping to correct hypocalcaemia.
The pharmacodynamic effect is an increase in serum calcium, which is why careful titration and monitoring are mandatory.
Clinical Terms
- ATC: A11CC04 — Vitamin D3 analogues.
- Calcitriol: Active form of vitamin D3 used for calcium metabolism disorders.
- Hypercalcaemia: Elevated serum calcium that can cause GI, neurological and cardiac effects.
- Titration: Gradual dose adjustment based on laboratory monitoring.
Clinicians should visualise calcitriol action as a loop between intestine (increased calcium absorption), bone (remodelling), kidney (phosphate handling) and parathyroid (PTH suppression), with clinical monitoring of calcium and phosphate required.
Indications & Off‑Label Uses
Approved Indications By TGA
Calcitriol is indicated for the treatment and prevention of hypocalcaemia, secondary hyperparathyroidism due to chronic kidney disease or dialysis, renal osteodystrophy and hypoparathyroidism.
Off‑Label Uses In Australian Clinical Practice
Topical calcitriol formulations are used for plaque psoriasis in some markets but are not interchangeable with oral or intravenous products for systemic conditions.
Other off‑label systemic uses should only be undertaken under specialist direction, such as rare metabolic bone diseases.
- Primary Indications: hypocalcaemia, CKD‑related hyperparathyroidism, hypoparathyroidism.
- Secondary/Off‑Label: select metabolic bone disorders with documented specialist oversight.
When using calcitriol off‑label document informed consent, specialist review and a clear monitoring plan in the medical record.
Key Clinical Findings
What does the evidence show about calcitriol?
Clinical trials and reviews demonstrate that calcitriol effectively treats hypocalcaemia and secondary hyperparathyroidism when used with appropriate monitoring.
The main risk is dose‑dependent hypercalcaemia which necessitates frequent laboratory checks during initiation and after dose changes.
Comparative data indicate that different vitamin D analogues vary in potency and side‑effect profile, with some agents like paricalcitol showing reduced hypercalcaemia risk in certain CKD settings.
Recent nephrology and endocrinology guidelines emphasise individualised titration and monitoring of calcium, phosphate and renal function.
- Efficacy: Effective for correcting hypocalcaemia when appropriately titrated.
- Safety: Mandatory monitoring due to risk of hypercalcaemia and downstream renal or cardiac complications.
- Drug Choice: Consider alternatives in patients at high risk of hypercalcaemia or with cardiac comorbidity.
- Specialist Care: Complex cases should be managed jointly by specialists and primary prescribers.
| Endpoint | Summary |
|---|---|
| Correction Of Hypocalcaemia | Consistently effective when doses are titrated to laboratory targets. |
| Risk Of Hypercalcaemia | Common dose‑dependent adverse effect requiring surveillance. |
| Comparative Safety | Some analogues may have lower hypercalcaemia risk in CKD; consult latest trials and guidelines. |
Label any trial data as evidence‑based and consult original studies and local guidelines for updates between 2022 and 2026.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Indication(s) | Relative Hypercalcaemia Risk | PBS Status | Pros / Cons |
|---|---|---|---|---|
| Alfacalcidol (One‑Alpha) | Similar indications to calcitriol in many settings | Comparable risk | Often PBS‑listed; check current listings | Pro: Widely used; Con: Requires activation in some settings. |
| Paricalcitol (Zemplar) | Secondary hyperparathyroidism in CKD | Lower hypercalcaemia risk in some studies | PBS status varies by indication | Pro: Potentially better safety in CKD; Con: Cost and subsidy considerations. |
| Doxercalciferol | Secondary hyperparathyroidism in selected patients | Variable | Check PBS | Pro: Specialist use; Con: Monitoring still required. |
| Cholecalciferol / Ergocalciferol (Native Vitamin D) | Vitamin D deficiency states; not a substitute in advanced CKD or hypoparathyroidism | Lower direct hypercalcaemia risk unless massively dosed | Widely available; PBS rules vary | Pro: Cheap and widely used; Con: Requires renal activation for effect so not suitable in severe CKD. |
Pros And Cons Checklist
- Onset Of Action: calcitriol is active immediately and useful where rapid correction of calcium is needed.
- Monitoring Intensity: calcitriol and active analogues require frequent calcium monitoring.
- Cost/PBS Subsidy: varies by agent and indication and affects choice in practice.
- Evidence In CKD: paricalcitol has trial data suggesting lower hypercalcaemia in some settings.
- Route: consider IV options (Calcijex) for inpatient or specialist use.
- Native Vitamin D: not a substitute when renal activation is impaired.
Discuss switching therapy with the treating clinician and document rationale and monitoring when changing agents.
Common Questions
- How often are blood tests required? Baseline, then 2–4 weekly during titration, then typically every 3–6 months once stable.
- Can I take calcium supplements? Only under clinician guidance and with adjusted monitoring to avoid hypercalcaemia.
- Pregnancy or breastfeeding? Specialist decision required; weigh risks and benefits.
- Can children take it? Yes when indicated with weight‑based dosing (0.01–0.02 mcg/kg/day) and close monitoring.
- Which questions need urgent referral? Signs of hypercalcaemia or cardiac symptoms require immediate clinical review.
When To Call Emergency:
- Severe vomiting, persistent confusion, major muscle weakness, collapse or loss of consciousness.
- Any sudden chest pain or severe palpitations suggestive of arrhythmia.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Pharmacy / Source | Typical Price Range | PBS Subsidy Status | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Varies by product and supply; check store for current pricing | Varies by indication; check PBS.gov.au | Yes |
| Priceline | Varies by product and supply; check store for current pricing | Varies by indication | Yes |
| TerryWhite Chemmart | Varies by product and supply; check store for current pricing | Varies by indication | Yes |
| Major Online Pharmacies | Varies; delivery charges may apply | Varies | Yes or supplied under online pharmacy protocols |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm a valid prescription and any PBS authority requirements before purchase.
- Verify the formulation required (capsule, oral solution, or injectable) and cold‑chain needs for injectables.
- Arrange local lab access for monitoring, especially for rural patients.
- Enquire about delivery options and pharmacist counselling availability when ordering online.
Registration & Regulation
TGA Approval
Calcitriol formulations are prescription only and individual product registrations are listed on the TGA ARTG; prescribers and pharmacists should verify the ARTG entry for the exact product supplied.
PBS Subsidy Details
Certain indications such as chronic renal disease and hypoparathyroidism may attract PBS subsidy and often require authority prescriptions.
For imported or parallel import products ensure compliance with TGA guidance and local pharmacovigilance reporting.
- Check the ARTG entry for the precise brand and formulation before supply.
- Confirm PBS schedule and authority requirements at PBS.gov.au for current subsidy status.
- Hospital IV formulations are typically supplied within hospital settings and are not routinely available in the community without specialist arrangement.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store calcitriol at room temperature, generally between 15–25°C, protected from light and moisture.
Keep oral solutions and capsules in their original packaging and do not freeze.
In very hot or humid regions store away from direct heat and avoid bathroom storage to reduce exposure to humidity.
Cold‑Chain Handling For Pharmacies
Injectable forms are provided as single‑use ampoules and should be stored and handled per the product monograph.
Follow cold‑chain procedures where specified by the manufacturer and discard any opened parenteral containers per local protocols.
- Patient counselling checklist: keep out of reach of children, check expiry dates, store away from bathroom humidity, and return unused injectables to the pharmacy for safe disposal.
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Start the counselling by confirming the indication and the exact formulation prescribed.
Explain expected benefits and the high importance of monitoring serum calcium, phosphate and renal function.
Highlight the signs of hypercalcaemia and what to do if they occur.
Advise avoiding over‑the‑counter calcium or vitamin D supplements unless authorised by the prescriber.
Cover missed dose instructions and emphasise never to double the dose after a missed dose.
- Short scripted checklist for a 2–3 minute consult: confirm identity and indication; state dose and timing; explain monitoring schedule; list red‑flag symptoms; confirm follow‑up lab arrangements.
Patient Advice From PBS And National Health Authorities
Advise patients to keep copies of lab results and to bring medicines to appointments for reconciliation.
Instruct them to seek immediate medical attention for severe vomiting, confusion, severe muscle weakness or fainting.
For suspected overdose: stop the medication, seek urgent medical assessment and bring medication packaging and recent labs to the emergency department.
Refer complex cases to specialist care and link patients to TGA and PBS resources for the most up to date regulatory information.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Cairns | Queensland | 14-21 days |